Unaudited Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities
Net loss	$ (18,055,480)	$ (3,935,055)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	2,033,752	1,812,893
Provision for losses on accounts receivable	16,970,555	9,329,683
Inventories impairment	3,969,293	1,691,679
Changes in operating assets
Digital assets	175,585
Accounts receivable	(15,259,021)	(14,159,591)
Amount due from related parties	27,787	(2,696)
Other current assets	199,768	(9,295,056)
Inventories	6,312,446	(4,593,619)
Advances to suppliers	(6,824,502)	12,028,741
Other assets	1,404,244	1,455,556
Deferred tax assets	(10,828)
Changes in operating liabilities
Accounts payable	(199,488)	276,584
Customer deposits	(335,612)	(673,151)
Amount due to related parties	(1,003)	(3,751)
Tax payables	(153,879)	7,826
Accrued expenses and other payables	2,430,107	1,328,059
Interest payable		(739,631)
Net cash used in operating activities	(7,316,276)	(5,471,529)
Cash flows from investing activities
Purchase of plant, property, and equipment	(1,651,010)	(309,514)
Investment	(2,450,000)
Sales of discontinued operations		901,109
Net cash (used in) provided by investing activities	(4,101,010)	591,595
Cash flows from financing activities
Proceeds from the sale of common stock		16,757,130
Proceeds from loans	2,778,662	2,884,076
Repayment of loans	(1,639,410)	(58,200)
Advance from related party	191,000	320,000
Net cash provided by financing activities	1,330,251	19,903,006
Effect of exchange rate change on cash and cash equivalents	540,604	(1,032,771)
Net (decrease) increase in cash and cash equivalents	(9,546,431)	13,990,301
Cash and cash equivalents, beginning balance	71,142,188	57,770,303
Cash and cash equivalents, ending balance	61,595,756	71,760,603
Supplement disclosure of cash flow information
Interest expense paid	216,828	216,391
Income taxes paid	$ 193,833	$ 330,861